205 related articles for article (PubMed ID: 8709234)
1. Characterization of human immunodeficiency virus type 1 Vif particle incorporation.
Camaur D; Trono D
J Virol; 1996 Sep; 70(9):6106-11. PubMed ID: 8709234
[TBL] [Abstract][Full Text] [Related]
2. Vif is largely absent from human immunodeficiency virus type 1 mature virions and associates mainly with viral particles containing unprocessed gag.
Sova P; Volsky DJ; Wang L; Chao W
J Virol; 2001 Jun; 75(12):5504-17. PubMed ID: 11356958
[TBL] [Abstract][Full Text] [Related]
3. The Vif protein of human and simian immunodeficiency viruses is packaged into virions and associates with viral core structures.
Liu H; Wu X; Newman M; Shaw GM; Hahn BH; Kappes JC
J Virol; 1995 Dec; 69(12):7630-8. PubMed ID: 7494271
[TBL] [Abstract][Full Text] [Related]
4. gag, vif, and nef genes contribute to the homologous viral interference induced by a nonproducer human immunodeficiency virus type 1 (HIV-1) variant: identification of novel HIV-1-inhibiting viral protein mutants.
D'Aloja P; Olivetta E; Bona R; Nappi F; Pedacchia D; Pugliese K; Ferrari G; Verani P; Federico M
J Virol; 1998 May; 72(5):4308-19. PubMed ID: 9557721
[TBL] [Abstract][Full Text] [Related]
5. Virion incorporation of human immunodeficiency virus type-1 Vif is determined by intracellular expression level and may not be necessary for function.
Simon JH; Miller DL; Fouchier RA; Malim MH
Virology; 1998 Sep; 248(2):182-7. PubMed ID: 9721227
[TBL] [Abstract][Full Text] [Related]
6. Human immunodeficiency virus type 1 Vif protein is an integral component of an mRNP complex of viral RNA and could be involved in the viral RNA folding and packaging process.
Zhang H; Pomerantz RJ; Dornadula G; Sun Y
J Virol; 2000 Sep; 74(18):8252-61. PubMed ID: 10954522
[TBL] [Abstract][Full Text] [Related]
7. The redox state of cysteines in human immunodeficiency virus type 1 Vif in infected cells and in virions.
Sova P; Chao W; Volsky DJ
Biochem Biophys Res Commun; 1997 Nov; 240(2):257-60. PubMed ID: 9388463
[TBL] [Abstract][Full Text] [Related]
8. Human immunodeficiency virus type 1 Vif does not influence expression or virion incorporation of gag-, pol-, and env-encoded proteins.
Fouchier RA; Simon JH; Jaffe AB; Malim MH
J Virol; 1996 Dec; 70(12):8263-9. PubMed ID: 8970945
[TBL] [Abstract][Full Text] [Related]
9. A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion.
Xu H; Svarovskaia ES; Barr R; Zhang Y; Khan MA; Strebel K; Pathak VK
Proc Natl Acad Sci U S A; 2004 Apr; 101(15):5652-7. PubMed ID: 15054139
[TBL] [Abstract][Full Text] [Related]
10. Human immunodeficiency virus type 1 Vif is efficiently packaged into virions during productive but not chronic infection.
Kao S; Akari H; Khan MA; Dettenhofer M; Yu XF; Strebel K
J Virol; 2003 Jan; 77(2):1131-40. PubMed ID: 12502829
[TBL] [Abstract][Full Text] [Related]
11. Human immunodeficiency virus type 1 Vif protein is packaged into the nucleoprotein complex through an interaction with viral genomic RNA.
Khan MA; Aberham C; Kao S; Akari H; Gorelick R; Bour S; Strebel K
J Virol; 2001 Aug; 75(16):7252-65. PubMed ID: 11461998
[TBL] [Abstract][Full Text] [Related]
12. Human immunodeficiency virus type 1 Vif- mutant particles from restrictive cells: role of Vif in correct particle assembly and infectivity.
Borman AM; Quillent C; Charneau P; Dauguet C; Clavel F
J Virol; 1995 Apr; 69(4):2058-67. PubMed ID: 7884851
[TBL] [Abstract][Full Text] [Related]
13. Biological activity of human immunodeficiency virus type 1 Vif requires membrane targeting by C-terminal basic domains.
Goncalves J; Shi B; Yang X; Gabuzda D
J Virol; 1995 Nov; 69(11):7196-204. PubMed ID: 7474141
[TBL] [Abstract][Full Text] [Related]
14. Cellular and viral specificities of human immunodeficiency virus type 1 vif protein.
Madani N; Kabat D
J Virol; 2000 Jul; 74(13):5982-7. PubMed ID: 10846079
[TBL] [Abstract][Full Text] [Related]
15. Association of human immunodeficiency virus type 1 Vif with RNA and its role in reverse transcription.
Dettenhofer M; Cen S; Carlson BA; Kleiman L; Yu XF
J Virol; 2000 Oct; 74(19):8938-45. PubMed ID: 10982337
[TBL] [Abstract][Full Text] [Related]
16. Influence of primate lentiviral Vif and proteasome inhibitors on human immunodeficiency virus type 1 virion packaging of APOBEC3G.
Liu B; Yu X; Luo K; Yu Y; Yu XF
J Virol; 2004 Feb; 78(4):2072-81. PubMed ID: 14747572
[TBL] [Abstract][Full Text] [Related]
17. Analysis of vif-defective human immunodeficiency virus type 1 (HIV-1) virions synthesized in 'non-permissive' T lymphoid cells stably infected with selectable HIV-1.
Ochsenbauer C; Wilk T; Bosch V
J Gen Virol; 1997 Mar; 78 ( Pt 3)():627-35. PubMed ID: 9049414
[TBL] [Abstract][Full Text] [Related]
18. Intravirion processing of the human immunodeficiency virus type 1 Vif protein by the viral protease may be correlated with Vif function.
Khan MA; Akari H; Kao S; Aberham C; Davis D; Buckler-White A; Strebel K
J Virol; 2002 Sep; 76(18):9112-23. PubMed ID: 12186895
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive investigation of the molecular defect in vif-deficient human immunodeficiency virus type 1 virions.
Gaddis NC; Chertova E; Sheehy AM; Henderson LE; Malim MH
J Virol; 2003 May; 77(10):5810-20. PubMed ID: 12719574
[TBL] [Abstract][Full Text] [Related]
20. Interaction and co-encapsidation of human immunodeficiency virus type 1 Gag and Vif recombinant proteins.
Huvent I; Hong SS; Fournier C; Gay B; Tournier J; Carrière C; Courcoul M; Vigne R; Spire B; Boulanger P
J Gen Virol; 1998 May; 79 ( Pt 5)():1069-81. PubMed ID: 9603321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
